Three biopharma executives discuss how a virtual JPM will impact the traditional sense of urgency around the conference, approaches to pitching, thoughts on operating at JPM post pandemic, along with some parting pearls of wisdom. This is part of a larger executive virtual roundtable (EVR) conducted by Rob Wright, chief editor of Life Science Leader, […]

In this video segment, three biopharma executives discuss the differences between preparing for JPM in-person versus virtual, and the pros and cons of each (e.g., using Zoom, Zoom fatigue, travel, and virtual networking receptions). This is part of a larger executive virtual roundtable (EVR) conducted by Rob Wright, chief editor of Life Science Leader, that […]

Rob Wright, chief editor of Life Science Leader, conducted an executive virtual roundtable (EVR) with In this video segment, three biopharma executives share examples of significant biopharmaceutical industry deals that have evolved out of JPM. This is part of a larger executive virtual roundtable (EVR) conducted by Rob Wright, chief editor of Life Science Leader, […]